当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第27期
编号:13106403
抗抑郁药物的联合用药研究进展(5)
http://www.100md.com 2017年9月25日 《中国医药导报》 2017年第27期
     [31] Salagre E,Fernandes BS,Dodd S,et al. Statins for the treatment of depression:A meta-analysis of randomized,double-blind,placebo-controlled trials [J]. J Affect Disord,2016,200:235-242.

    [32] Gougol A,Zareh-Mohammadi N,Raheb S,et al.Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression:A double-blind placebo-controlled trial [J]. J Psychopharmacol,2015,9(5):575-581.

    [33] Ghanizadeh A,Hedayati A. Augmentation of fluoxetine with lovastatin for treating major depressive disorder,a randomized double-blind placebo controlled-clinical trial [J]. Depress Anxiety,2013,30(11):1084-1088.

    [34] Renshaw PF,Parsegian A,Yang CK,et al. Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats [J]. Pharmacol Biochem Behav,2009,92(1):88-92.

    [35] Andrade C. Selective serotonin reuptake inhibitor drug interactions in patients receiving statins [J]. J Clin Psychiatry,2014,75(2):5-9.

    [36] Herbet M,Gawrońska-Grzywacz M,Izdebska M,et al. Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in rats [J]. Exp Ther Med,2016,11(4):1459-1464.

    (收稿日期:2017-06-20 本文編辑:程 铭), http://www.100md.com(苑杰 高静 肖健)
上一页1 2 3 4 5